KRED

Tuesday, March 21, 2017

Delivra Signs Exclusive Licensing Deal with Dosecann for Cannabis Oil Formulations in Metered Dose Formats

http://ift.tt/eA8V8J

TORONTO, ON--(Marketwired - March 21, 2017) - Delivra Corp. (TSX VENTURE: DVA) ("Delivra" or the "Company"), Dosecann Inc. ("Dosecann") and ARA-Avanti Rx Analytics Inc. ("Avanti") announced today a strategic partnership to develop a unique suite of standardized products for the medical cannabis research, development, and commercialization markets.



March 21, 2017 at 04:42PM

http://ift.tt/2moeduG

from

http://ift.tt/2moeduG